The effects of antifungal stewardship programs at a tertiary-care teaching hospital in Japan

Patients with invasive fungal diseases (IFDs) generally have a high mortality rate, and resistance to antifungal drugs and the high costs associated with it have led to recent problems, necessitating the appropriate use of antifungals. To this end, we launched Antifungal Stewardship Programs (AFSPs)...

Full description

Saved in:
Bibliographic Details
Published inJournal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy Vol. 25; no. 6; pp. 458 - 462
Main Authors Kawaguchi, Hiroshi, Yamada, Koichi, Imoto, Waki, Yamairi, Kazushi, Shibata, Wataru, Namikawa, Hiroki, Yoshii, Naoka, Nakaie, Kiyotaka, Okada, Yasuyo, Fujita, Akiko, Shinoda, Yoshikatsu, Nakamura, Yasutaka, Kaneko, Yukihiro, Nagayama, Katsuya, Kakeya, Hiroshi
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Ltd 01.06.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Patients with invasive fungal diseases (IFDs) generally have a high mortality rate, and resistance to antifungal drugs and the high costs associated with it have led to recent problems, necessitating the appropriate use of antifungals. To this end, we launched Antifungal Stewardship Programs (AFSPs) in our hospital. Patients who were systemically administered antifungals from January 2011 to December 2016 were enrolled this study and divided into pre-intervention and intervention groups. No significant difference was observed in defined daily doses per 1000 patient-days (23.3 ± 8.0 vs 20.4 ± 10.8, p = 0.251) between the groups. The monthly average for the days of therapy per 1000 patient-days was significantly lower in the intervention group (15.1 ± 3.1 vs 12.7 ± 4.3, p = 0.009). The cost of the antifungals reduced over the 3-year period by $260,520 (13.5%). Furthermore, a decreasing trend was observed in both the 30-day mortality (40.9% vs 30.0%, p = 0.414) and in-hospital mortality (63.6% vs 36.7%, p = 0.054) in patients with candidemia. Our results indicate that AFSPs are efficacious and cost-effective approaches.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1341-321X
1437-7780
DOI:10.1016/j.jiac.2019.01.015